These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 686104)

  • 1. Effects of steroids on serum lipids and serum cholesterol binding reserve.
    Roth MS; Donato DM; Lansman HH; Robertson EG; Hsia SL; LeMaire WJ
    Am J Obstet Gynecol; 1978 Sep; 132(2):151-6. PubMed ID: 686104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between levels of blood lipids, vitamins C, A, and E, serum copper compounds, and urinary excretions of tryptophan metabolites in women taking oral contraceptive therapy.
    Horwitt MK; Harvey CC; Dahm CH
    Am J Clin Nutr; 1975 Apr; 28(4):403-12. PubMed ID: 1119436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral contraceptive steroids and atherosclerosis: lipogenesis in human arterial smooth muscle cells and dermal fibroblasts in presence of lipoprotein-deficient serum from oral contraceptive users.
    Subbaiah PV; Bagdade JD
    Artery; 1980; 6(6):437-57. PubMed ID: 7436743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of kind of carbohydrate in the diet and use of oral contraceptives on metabolism of young women. II. Serum lipid levels.
    Behall KM; Moser PB; Kelsay JL; Prather ES
    Am J Clin Nutr; 1980 Apr; 33(4):825-31. PubMed ID: 7361701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of oral contraceptives on serum lipids.
    Schenker JG; Pinson A; Polishuk WZ
    Fertil Steril; 1971 Sep; 22(9):604-8. PubMed ID: 5571067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of menopausal status and sequential mestranol and norethisterone on serum cholesterol, triglyceride and electrophoretic lipoprotein patterns.
    Paterson ME; Sturdee DW; Moore B; Whitehead TP
    Br J Obstet Gynaecol; 1979 Oct; 86(10):810-5. PubMed ID: 508663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Massive hyperlipemia during estrogen therapy.
    Molitch ME; Oill P; Odell WD
    JAMA; 1974 Feb; 227(5):522-5. PubMed ID: 4358883
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum-lipids in women on oral contraceptives.
    Stokes T; Wynn V
    Lancet; 1971 Sep; 2(7726):677-80. PubMed ID: 4105711
    [No Abstract]   [Full Text] [Related]  

  • 15. Progestogens and arterial disease--evidence from the Royal College of General Practitioners' study.
    Kay CR
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):762-5. PubMed ID: 6801981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of oral contraceptives on lipoprotein triglyceride and cholesterol: relationships to estrogen and progestin potency.
    Knopp RH; Walden CE; Wahl PW; Hoover JJ
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):725-31. PubMed ID: 7065054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased serum cholesterol-binding reserve in diabetes mellitus.
    Hsia SL; Fishman LM; Briese FW; Christakis G; Burr J; Bricker LA
    Diabetes Care; 1978; 1(2):89-93. PubMed ID: 215396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of oral contraceptive steroids on serum lipids.
    De Alvarez RR; Jahed FM; Spitalny KJ; Elkin H; Jaunakais I
    Am J Obstet Gynecol; 1973 Jul; 116(5):727-49. PubMed ID: 4351501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid metabolic studies in oophorectomized women: effects induced by two different estrogens on serum lipids and lipoproteins.
    Silfverstolpe G; Gustafson A; Samsioe G; Svanborg A
    Gynecol Obstet Invest; 1980; 11(3):161-9. PubMed ID: 7439809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenteric venous thrombosis and oral contraceptives.
    Nesbit RR; Deweese JA
    South Med J; 1977 Mar; 70(3):360-2. PubMed ID: 847490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.